Madrigal Pharmaceuticals (MDGL) PT Raised to $375 at Oppenheimer
Tweet
Share
E-mailGet Alerts MDGL Hot Sheet
Price: $505.75 +1.18%
Rating Summary:
20 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Rating Summary:
20 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Join SI Premium – FREE
Oppenheimer analyst Jay Olson raised the price target on Madrigal Pharmaceuticals (NASDAQ: MDGL) to $375.00 (from $320.00) while maintaining a Outperform rating.
You May Also Be Interested In
- CLSA Downgrades Subaru Corp. (7270:JP) (FUJHY) to Outperform (2)
- Zehnder Group AG (ZEHN:SW) PT Lowered to CHF86 at UBS
- Bayerische Motoren Werke AG (BMW:GR) (BMWYY) PT Lowered to EUR70 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
